Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1p6x | THM | Thymidine kinase |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1p6x | THM | Thymidine kinase | / | 1.000 | |
| 1p72 | THM | Thymidine kinase | / | 0.757 | |
| 5jqh | CAU | Beta-2 adrenergic receptor | / | 0.496 | |
| 4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.493 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.490 | |
| 3u9f | CLM | Chloramphenicol acetyltransferase | 2.3.1.28 | 0.490 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.487 | |
| 3ny8 | JRZ | Beta-2 adrenergic receptor | / | 0.479 | |
| 3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.477 | |
| 1ygk | RRC | Pyridoxal kinase | 2.7.1.35 | 0.476 | |
| 3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.476 | |
| 2wu4 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.472 | |
| 4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.472 | |
| 5c1g | GDU | Histo-blood group ABO system transferase | / | 0.472 | |
| 2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.471 | |
| 4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.471 | |
| 2jj8 | AZZ | Deoxynucleoside kinase | / | 0.470 | |
| 4n3r | 2GU | Tankyrase-1 | 2.4.2.30 | 0.470 | |
| 2gyw | OBI | Acetylcholinesterase | 3.1.1.7 | 0.467 | |
| 3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.467 | |
| 4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.466 | |
| 1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
| 5c1m | CLR | Mu-type opioid receptor | / | 0.464 | |
| 2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
| 2vqs | BVD | Deoxynucleoside kinase | / | 0.461 | |
| 2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.460 | |
| 4j8t | DOG | Uncharacterized PhzA/B-like protein PA3332 | / | 0.460 | |
| 4s0v | SUV | Orexin receptor type 2 | / | 0.460 | |
| 1xl8 | 152 | Peroxisomal carnitine O-octanoyltransferase | 2.3.1.137 | 0.459 | |
| 4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
| 4ami | G90 | Beta-1 adrenergic receptor | / | 0.459 | |
| 3d4s | TIM | Beta-2 adrenergic receptor | / | 0.459 | |
| 3r7m | SUZ | Aldo-keto reductase family 1 member C3 | / | 0.458 | |
| 1pq6 | 965 | Oxysterols receptor LXR-beta | / | 0.457 | |
| 2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.457 | |
| 1icq | OPD | 12-oxophytodienoate reductase 1 | 1.3.1.42 | 0.456 | |
| 1r5g | AO1 | Methionine aminopeptidase 2 | / | 0.456 | |
| 3nya | JTZ | Beta-2 adrenergic receptor | / | 0.456 | |
| 2xui | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.455 | |
| 3frk | TQP | QdtB | / | 0.455 | |
| 3pqb | VGP | Putative oxidoreductase | / | 0.455 | |
| 4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.455 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.455 | |
| 1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.454 | |
| 2zi5 | 3L1 | Deoxycytidine kinase | 2.7.1.74 | 0.454 | |
| 4zj8 | SUV | Orexin receptor type 1 | / | 0.454 | |
| 1amo | FAD | NADPH--cytochrome P450 reductase | / | 0.453 | |
| 2cbq | TH2 | Neocarzinostatin | / | 0.453 | |
| 2gyu | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
| 2xi4 | AFT | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
| 3sqz | COA | Putative hydroxymethylglutaryl-CoA synthase | / | 0.452 | |
| 1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
| 2xuq | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.451 | |
| 3a25 | SAM | tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase | / | 0.450 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.450 | |
| 3ihg | VAK | Aklavinone 12-hydroxylase RdmE | / | 0.450 | |
| 4kxj | P34 | Nucleoprotein | / | 0.450 | |
| 4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.450 | |
| 2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.449 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.448 | |
| 4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
| 4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.448 | |
| 5d6l | CAU | Beta-2 adrenergic receptor | / | 0.448 | |
| 3dys | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
| 4a6r | TA8 | Probable aminotransferase | / | 0.447 | |
| 4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.447 | |
| 4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
| 4arb | C57 | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
| 4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.446 | |
| 4n9q | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.446 | |
| 1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.445 | |
| 2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.445 | |
| 2ycw | CAU | Beta-1 adrenergic receptor | / | 0.445 | |
| 3dyl | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
| 3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.445 | |
| 2ycx | P32 | Beta-1 adrenergic receptor | / | 0.445 | |
| 1ejb | INJ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.444 | |
| 3fzn | D7K | Benzoylformate decarboxylase | 4.1.1.7 | 0.444 | |
| 3ou2 | SAH | SAM-dependent methyltransferase | / | 0.444 | |
| 4n1f | CZH | Obelin | / | 0.444 | |
| 3ny9 | JSZ | Beta-2 adrenergic receptor | / | 0.444 | |
| 1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.443 | |
| 5d5b | CAU | Beta-2 adrenergic receptor | / | 0.443 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
| 3pm1 | ET | HTH-type transcriptional regulator QacR | / | 0.442 | |
| 4da0 | GNG | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.442 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.441 | |
| 3vi5 | M4M | Hematopoietic prostaglandin D synthase | / | 0.441 | |
| 5a8e | XTK | Beta-1 adrenergic receptor | / | 0.441 | |
| 1w4l | GL8 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
| 1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.440 | |
| 2aov | C2M | Histamine N-methyltransferase | 2.1.1.8 | 0.440 | |
| 2xuh | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
| 3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 3uwe | VJJ | Aldo-keto reductase family 1 member C3 | / | 0.440 | |
| 4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.440 |